IndraLab

Statements

YOD1 binds Circulin-C. 22 / 22
| 22
sparser
"The results of pairwise comparison showed a statistically significant difference for circ-YOD1 ( P YOD1-21  < 0.01; P YOD1-296  < 0.05, Fig.  xref )."
31797949
sparser
"Our investigation of the triple regulatory networks of circRNA-miRNA-mRNA in CAD revealed circ-YOD1 as a potential biomarker for CAD."
31797949
sparser
"Two of these miRNAs were related to CAD xref , xref and can be regulated by circ-YOD1."
31797949
sparser
"The expression levels of BCL6 , FBXL18 , MMP9 and FCGR3B were significantly upregulated in the overexpression circ-YOD1 group compared with the negative control."
31797949
sparser
"Then, the expression levels of miR-21-3p and miR-296-3p were downregulated significantly in the overexpression circ-YOD1 group compared to the negative control."
31797949
sparser
"Therefore, we hypothesized that circ-YOD1 could play a negative regulatory role on miR-21-3p/miR-296-3p expression in CAD."
31797949
sparser
"The head-to-tail splicing in the RT-qPCR product of circ-YOD1 was confirmed by Sanger sequencing and is shown in Fig.  xref ."
31797949
sparser
"Miao et al. established a triple regulatory network of circRNA-miRNA-mRNA and found circ-YOD1 could be a good marker to predict the onset of CAD [ xref ]."
35223093
sparser
"Thus, Circ-YOD1 may regulate parental gene YOD1 expression that leads to CAD."
31797949
sparser
"For example, circ-YOD1 was considered as a biomarker for coronary artery disease [ xref ], and circDLPAG4 was identified as a potential therapeutic target for myocardial ischemia [ xref ]."
33869778
sparser
"The result of ROC curve analysis showed that the 95% confidence interval (CI) of circ-YOD1 was 0.745–0.904, and the AUC was 0.824."
31797949
sparser
"The area under ROC curve (AUC) of circ-YOD1 was 0.824, the AUC of hsa-miR-21-3p was 0.731 and hsa-miR-296-3p was 0.776."
31797949
sparser
"The results of functional enrichment analysis of interacting genes and microRNAs showed that the shared circ-YOD1 may act as a new biomarker for CAD."
31797949
sparser
"After transfection with siRNA or the circ-YOD1 overexpression vector, circ-YOD1 expression was identified using qRT-PCR in THP-1 cells and HASMCs (Fig.  xref )."
31797949
sparser
"Accordingly, downregulation of circ-YOD1 expression could reduce the expression of BCL6 , FBXL18 , MMP9 and FCGR3B as shown by transfecting THP-1 cells and HASMCs with siRNAs (Fig.  xref )."
31797949
sparser
"These results indicate that circ-YOD1 may be a good predictive candidate biomarker for the diagnosis of CAD."
31797949
sparser
"Several other specific conditions, such as coronary artery disease and nonvalvular persistent atrial fibrillation, have been associated with circRNAs, suggesting, respectively, that circ-YOD1 is a potential biomarker [ xref ] and that circRNA002085 and circRNA001321 show evidence of circRNA-associated ceRNA mechanisms [ xref ]."
32605220
sparser
"Accordingly, downregulation of circ-YOD1 expression could increase the expression of miR-21-3p and miR-296-3p as analyzed after transfecting THP-1 cells and HASMCs with siRNAs against circ-YOD1 (Fig.  xref )."
31797949
sparser
"The pairwise comparison results showed that circ-YOD1 had statistical significance ( P YOD1-21  < 0.01 and P YOD1-296  < 0.05)."
31797949
sparser
"Compared to controls, we found that the related expression of circ-YOD1 was significantly increased in CAD patients, but hsa-miR-21-3p and hsa-miR-296-3p were reduced (Fig.  xref )."
31797949
sparser
"Second, without a sufficient luciferase assay, we only identified circ-YOD1 as a biomarker for CAD."
31797949
sparser
"Thus, we performed an integrated bioinformatic analysis and speculated that circ-YOD1 may serve as a diagnostic or prognostic biomarker of CAD and have potential therapeutic value."
31797949